• 31

• March

• 2025

Crown Laboratories Now Operates Under the Name Revance

LEARN MORE

• 06

• February

• 2025

Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics

LEARN MORE

• 05

• February

• 2025

Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer

LEARN MORE

• 31

• January

• 2025

Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline

LEARN MORE

• 08

• August

• 2023

Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update

LEARN MORE

• 01

• August

• 2023

Revance to Release Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

LEARN MORE